Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

19/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Conformis, Inc. (CFMS) .

本頁證實的標準:

VALUE (0/100, 未通過) — 綜合估值評分低於60/100的通過門檻。

SharesGrow 綜合評分： 19/100 其中 0/7 項標準通過。

SharesGrow 7-Criteria Score

19/100

SG Score

View full scorecard →

—

價值

N/A

No coverage

✗

未來

20/100

Analyst consensus

→ Forecast

✗

過去

0/100

→ Income

健康

50/100

Debt-to-Equity & liquidity

→ Health

✗

護城河

21/100

→ Income

✗

成長

15/100

→ Income

✗

收入

10/100

→ Income

估值概覽 — CFMS

估值倍數

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.26

EV/EBITDA0.0

每股數據

EPS (TTM)$-6.99

每股帳面價值$0.00

每股營收$8.59

每股自由現金流$0.00

收益率與內在價值

盈利收益率N/A

股息收益率0.00%

EPS：實際 vs 預期

P/E Ratio & Earnings Yield

每股盈餘 (EPS) 歷史

Year	EPS（稀釋）	營收	淨利潤	淨利潤率
2013	$-277.18	$34.6M	$-47.89M	-138.4%
2014	$-264.64	$48.19M	$-45.72M	-94.9%
2015	$-65.07	$66.89M	$-57.25M	-85.6%
2016	$-34.67	$79.9M	$-57.59M	-72.1%
2017	$-30.90	$78.12M	$-53.58M	-68.6%
2018	$-18.41	$89.79M	$-43.37M	-48.3%
2019	$-11.10	$77.43M	$-28.48M	-36.8%
2020	$-8.47	$68.76M	$-24.29M	-35.3%
2021	$-0.36	$99.86M	$-2.41M	-2.4%
2022	$-6.99	$62.05M	$-50.47M	-81.3%